Cargando…

Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer

BACKGROUND: Currently there is no reports on identifying molecular markers for pre-thrombotic state in animal experimental settings. It’s necessary to explore the potential molecular markers for pre-thrombotic state to provide evidence for the pharmacotherapy of venous thromboembolism (VTE). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Yan, Hu, Xin, Chen, Jing, Wu, Qian, Ying, Xiaobin, Shi, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799274/
https://www.ncbi.nlm.nih.gov/pubmed/35116984
http://dx.doi.org/10.21037/tcr.2019.09.44
_version_ 1784642032863543296
author Qi, Yan
Hu, Xin
Chen, Jing
Wu, Qian
Ying, Xiaobin
Shi, Yan
author_facet Qi, Yan
Hu, Xin
Chen, Jing
Wu, Qian
Ying, Xiaobin
Shi, Yan
author_sort Qi, Yan
collection PubMed
description BACKGROUND: Currently there is no reports on identifying molecular markers for pre-thrombotic state in animal experimental settings. It’s necessary to explore the potential molecular markers for pre-thrombotic state to provide evidence for the pharmacotherapy of venous thromboembolism (VTE). METHODS: A total of 36 male rabbits were randomly divided into Sham, Tibia fracture, Lung cancer, Tibia fracture and lung cancer group. Pro-thrombin time (PT), thrombin time (TT), activated partial pro-thrombin time (APTT), fibrinogen (FIB), D-dimer (D-D) and anti-thrombin III (AT-III) at baseline, 1, 7, 14 and 21 days after operation were detected. Immuno-histochemical staining of tumor tissue sections was performed to observe the expression of CD31, VEGF and vWF. Western blot and qPCR were used to detect the expression levels of ANG and VEGF gene in tumor tissues. Furthermore, we analyzed the tumor tissue with HE staining, immunochemistry, qPCR and Western blot. all the data were statistically analyzed with GraphPad Prism 6. RESULTS: There were 0, 1, 2, 4 cases of VTE in sham, tibia fracture, lung cancer, tibia fracture and lung cancer group respectively. The level of PT, APTT, TT and AT-III were significantly decreased after operation (all P<0.05), whereas the level of FIB and D-D were significantly increased after operation (all P<0.05). The level of PT, APTT, TT and AT-III were gradually decreased in tibia fracture, lung cancer, tibia fracture and lung cancer group respectively (all P<0.05), while the level of FIB and D-D were gradually increased in tibia fracture, lung cancer, tibia fracture and lung cancer group respectively (all P<0.05). The medullary lymphocytes increased significantly in the lung cancer group, tibia fracture and lung cancer group (all P<0.05), and the number of medullary lymphocytes in tibia fracture and lung cancer group is significantly higher than that of lung cancer group (P<0.001). The expression of CD31, VEGF and vWF in Tibia fracture and lung cancer group is significantly higher than that of lung cancer group (all P<0.001). The expression ANG and VEGF in tibia fracture and lung cancer group is significantly higher than that of lung cancer group (all P<0.01). CONCLUSIONS: PT, TT, APTT, FIB, D-D and AT-III seem to be sensitive molecular markers for identifying the pre-thrombotic state. CD31, VEGF, ANG and vWF play an important role in the progression of the pre-thrombotic state.
format Online
Article
Text
id pubmed-8799274
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87992742022-02-02 Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer Qi, Yan Hu, Xin Chen, Jing Wu, Qian Ying, Xiaobin Shi, Yan Transl Cancer Res Original Article BACKGROUND: Currently there is no reports on identifying molecular markers for pre-thrombotic state in animal experimental settings. It’s necessary to explore the potential molecular markers for pre-thrombotic state to provide evidence for the pharmacotherapy of venous thromboembolism (VTE). METHODS: A total of 36 male rabbits were randomly divided into Sham, Tibia fracture, Lung cancer, Tibia fracture and lung cancer group. Pro-thrombin time (PT), thrombin time (TT), activated partial pro-thrombin time (APTT), fibrinogen (FIB), D-dimer (D-D) and anti-thrombin III (AT-III) at baseline, 1, 7, 14 and 21 days after operation were detected. Immuno-histochemical staining of tumor tissue sections was performed to observe the expression of CD31, VEGF and vWF. Western blot and qPCR were used to detect the expression levels of ANG and VEGF gene in tumor tissues. Furthermore, we analyzed the tumor tissue with HE staining, immunochemistry, qPCR and Western blot. all the data were statistically analyzed with GraphPad Prism 6. RESULTS: There were 0, 1, 2, 4 cases of VTE in sham, tibia fracture, lung cancer, tibia fracture and lung cancer group respectively. The level of PT, APTT, TT and AT-III were significantly decreased after operation (all P<0.05), whereas the level of FIB and D-D were significantly increased after operation (all P<0.05). The level of PT, APTT, TT and AT-III were gradually decreased in tibia fracture, lung cancer, tibia fracture and lung cancer group respectively (all P<0.05), while the level of FIB and D-D were gradually increased in tibia fracture, lung cancer, tibia fracture and lung cancer group respectively (all P<0.05). The medullary lymphocytes increased significantly in the lung cancer group, tibia fracture and lung cancer group (all P<0.05), and the number of medullary lymphocytes in tibia fracture and lung cancer group is significantly higher than that of lung cancer group (P<0.001). The expression of CD31, VEGF and vWF in Tibia fracture and lung cancer group is significantly higher than that of lung cancer group (all P<0.001). The expression ANG and VEGF in tibia fracture and lung cancer group is significantly higher than that of lung cancer group (all P<0.01). CONCLUSIONS: PT, TT, APTT, FIB, D-D and AT-III seem to be sensitive molecular markers for identifying the pre-thrombotic state. CD31, VEGF, ANG and vWF play an important role in the progression of the pre-thrombotic state. AME Publishing Company 2019-10 /pmc/articles/PMC8799274/ /pubmed/35116984 http://dx.doi.org/10.21037/tcr.2019.09.44 Text en 2019 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Qi, Yan
Hu, Xin
Chen, Jing
Wu, Qian
Ying, Xiaobin
Shi, Yan
Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title_full Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title_fullStr Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title_full_unstemmed Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title_short Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
title_sort identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799274/
https://www.ncbi.nlm.nih.gov/pubmed/35116984
http://dx.doi.org/10.21037/tcr.2019.09.44
work_keys_str_mv AT qiyan identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer
AT huxin identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer
AT chenjing identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer
AT wuqian identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer
AT yingxiaobin identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer
AT shiyan identificationofmolecularmarkersforprethromboticstatevalidationintherabbitswithtibiafractureorlungcancer